These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 37497527)
1. First insights from patients presenting with long/post-COVID syndrome in primary care: an exploratory report. Sotiriadou M; Birka S; Oikonomidou E; Κouzoukidou E; Mpogiatzidis P Hippokratia; 2022; 26(4):138-142. PubMed ID: 37497527 [TBL] [Abstract][Full Text] [Related]
2. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related]
3. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic. Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359 [TBL] [Abstract][Full Text] [Related]
4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
5. Sex-Related Differences in Long-COVID-19 Syndrome. Pelà G; Goldoni M; Solinas E; Cavalli C; Tagliaferri S; Ranzieri S; Frizzelli A; Marchi L; Mori PA; Majori M; Aiello M; Corradi M; Chetta A J Womens Health (Larchmt); 2022 May; 31(5):620-630. PubMed ID: 35333613 [No Abstract] [Full Text] [Related]
6. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A; Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186 [TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
8. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi. Aggarwal A; Shrivastava A; Kumar A; Ali A J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676 [TBL] [Abstract][Full Text] [Related]
10. Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study. Chudzik M; Babicki M; Kapusta J; Kałuzińska-Kołat Ż; Kołat D; Jankowski P; Mastalerz-Migas A Viruses; 2022 Aug; 14(8):. PubMed ID: 36016376 [TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area. Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712 [TBL] [Abstract][Full Text] [Related]
12. Female gender is associated with long COVID syndrome: a prospective cohort study. Bai F; Tomasoni D; Falcinella C; Barbanotti D; Castoldi R; Mulè G; Augello M; Mondatore D; Allegrini M; Cona A; Tesoro D; Tagliaferri G; Viganò O; Suardi E; Tincati C; Beringheli T; Varisco B; Battistini CL; Piscopo K; Vegni E; Tavelli A; Terzoni S; Marchetti G; Monforte AD Clin Microbiol Infect; 2022 Apr; 28(4):611.e9-611.e16. PubMed ID: 34763058 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of post-acute-COVID-19, and long-COVID symptoms with a questionnaire: Within one year, a longitudinal study. Emiroglu C; Dicle M; Ozagar SD; Gorpelioglu S; Aypak C North Clin Istanb; 2024; 11(2):105-114. PubMed ID: 38757107 [TBL] [Abstract][Full Text] [Related]
14. Post COVID-19 sequelae: A prospective observational study from Northern India. Naik S; Haldar SN; Soneja M; Mundadan NG; Garg P; Mittal A; Desai D; Trilangi PK; Chakraborty S; Begam NN; Bhattacharya B; Maher G; Mahishi N; Rajanna C; Kumar SS; Arunan B; Kirtana J; Gupta A; Patidar D; Kodan P; Sethi P; Ray A; Jorwal P; Kumar A; Nischal N; Sinha S; Biswas A; Wig N Drug Discov Ther; 2021 Nov; 15(5):254-260. PubMed ID: 34719599 [TBL] [Abstract][Full Text] [Related]
15. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209 [TBL] [Abstract][Full Text] [Related]